Shares of Elevance Health have moved -0.2% today, and are now trading at a price of $341.58. In contrast, the S&P 500 index saw a 1.0% change. Today's trading volume is 564,017 compared to the stock's average volume of 2,124,454.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. Based in Indianapolis, United States the company has 104,200 full time employees and a market cap of $75,913,428,992. Elevance Health currently offers its equity investors a dividend that yields 2.0% per year.
The company is now trading -12.11% away from its average analyst target price of $388.63 per share. The 19 analysts following the stock have set target prices ranging from $297.0 to $507.0, and on average give Elevance Health a rating of buy.
Over the last 12 months ELV shares have declined by -18.0%, which represents a difference of -34.6% when compared to the S&P 500. The stock's 52 week high is $458.75 per share and its 52 week low is $273.71. With its net margins declining an average -6.3% over the last 6 years, Elevance Health declining profitability gives us reason to believe its stock price will continue to underwhelm.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 177,011,000 | 5,980,000 | 3 | 0.0 |
| 2023 | 171,340,000 | 5,987,000 | 3 | -25.0 |
| 2022 | 156,595,000 | 5,894,000 | 4 | 0.0 |
| 2021 | 138,639,000 | 6,158,000 | 4 | 0.0 |
| 2020 | 121,867,000 | 4,572,000 | 4 | -20.0 |
| 2019 | 104,213,000 | 4,807,000 | 5 |
